Performance of the BACTEC MGIT 960 compared with solid media for detection of Mycobacterium in Bangkok, Thailand

Diagnostic Microbiology and Infectious Disease

Volumn 61, Issue 4, 2008, Pages 402-407

  Srisuwanvilai, La ong ^a   Monkongdee, Patama ^b   Podewils, Laura Jean ^c   Ngamlert, Keerataya ^a   Pobkeeree, Vallerut ^b   Puripokai, Panitchaya ^a   Kanjanamongkolsiri, Photjanart ^a   Subhachaturas, Wonchat ^a   Akarasewi, Pasakorn ^b   Wells, Charles D ^c   Tappero, Jordan W ^b,c   Varma, Jay K ^b,c  

^a Bangkok Metropolitan Health Administration   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Diagnosis; HIV AIDS; MGIT; Surveillance; Tuberculosis

Indexed keywords

ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CULTURE MEDIUM; EVALUATION; HUMAN; LIQUID CULTURE; MYCOBACTERIUM; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPUTUM; THAILAND; TUBERCULOSIS;

BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; SENSITIVITY AND SPECIFICITY; SPUTUM; THAILAND; TIME FACTORS; TUBERCULOSIS;

EID: 47249095316     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.02.015     Document Type: Article

References (25)

1. Canetti G., Fox W., Khomenko A., Mahler H.T., Menon N.K., Mitchison D.A., Rist N., and Smelev N.A. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. W.H.O. 41 (1969) 21-43
2. Cox H.S., Niemann S., Ismailov G., Doshetov D., Orozco J.D., Blok L., Rusch-Gerdes S., and Kebede Y. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin. Infect. Dis. 44 (2007) 1421-1427
3. Cruciani M., Scarparo C., Malena M., Bosco O., Serpelloni G., and Mengoli C. Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J. Clin. Microbiol. 42 (2004) 2321-2325
4. Getahun H., Harrington M., O'Brien R., and Nunn P. Diagnosis of smear-negative pulmonary TB in people living with HIV/AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369 (2007) 2042-2049
5. Githui W.A. Laboratory methods for diagnosis and detection of drug resistant Mycobacterium tuberculosis complex with reference to developing countries: a review. East Afr. Med. J. 79 (2002) 242-248
6. Hanna B.A., Ebrahimzadeh A., Elliott L.B., Morgan M.A., Novak S.M., Rusch-Gerdes S., Acio M., Dunbar D.F., Holmes T.M., Rexer C.H., Savthyakumar C., and Vannier A.M. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J. Clin. Microbiol. 37 (1999) 748-752
7. Idigoras P., Beristain X., Iturzaeta A., Vicente D., and Perez-Trallero E. Comparison of the automated nonradiometric Bactec MGIT 960 system with Lowenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 350-354
8. International Union Against Tuberculosis and Lung Disease (IUATLD). Technical Guide: Sputum Examination for Tuberculosis by Direct Microscopy in Low Income Countries (2000), IUATLD, Paris
9. Joh J.S., Lee C.H., Lee J.E., Park Y.K., Bai G.H., Kim E.C., Han S.K., Shim Y.S., and Yim J.J. The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J. Korean Med. Sci. 22 (2007) 26-29
10. Kanchana M., Cheke D., Natyshak I., Connor B., Warner A., and Martin T. Evaluation of the BACTEC MGIT 960 system for the recovery of mycobacteria. Diagn. Microbiol. Infect. Dis. 37 (2000) 31-36
11. Lee J.-J., Suo J., Lin C.-B., Wang J.-D., Lin T.-Y., and Tsai Y.-C. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int. J. Tuberc. Lung Dis. 7 (2003) 569-574
12. Lu D., Heeren B., and Dunne W. Comparison of the automated mycobacteria growth indicator tube system (BACTEC 960/MGIT) with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Microbiol. Infect. Dis. 118 (2002) 542-545
13. Macondo E.A., Ba F., Toure-Kane N.C., Kaire O., Gueye-Ndiaye A., Gaye-Diallo A., Boye C.S., and Mboup S. Improvement of tuberculosis diagnosis by the mycobacteria growth indicator tube (MGIT) in a developing country laboratory. Bull. Soc. Pathol. Exot. (1990) 93 (2000) 97-100
14. Moore D.A., Evans C.A., Gilman R.H., Caviedes L., Coronel J., Vivar A., Sanchez E., Piñedo Y., Saravia J.C., Salazar C., Oberhelman R., Hollm-Delgado M.G., LaChira D., Escombe A.R., and Friedland J.S. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. New Engl. J. Med. 355 (2006) 1539-1550
15. Rishi S., Sinha P., Malhotra B., and Pal N. A comparative study for the detection of mycobacteria by bactec MGIT 960, Lowenstein Jensen media and direct AFB smear examination. Indian J. Med. Microbiol. 25 (2007) 383-386
16. Rivera A.B., Tupasi T.E., Grimaldo E.R., Cardano R.C., and Co V.M. Rapid and improved recovery rate of Mycobacterium tuberculosis in mycobacteria growth indicator tube combined with solid Lowenstein Jensen medium. Int. J. Tuberc. Lung Dis. 1 (1997) 454-459
17. Steingart K.R., Ng V., Henry M., Hopewell P.C., Ramsay A., Cunningham J., Urbanczik R., Perkins M.D., Aziz M.A., and Pai M. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis. 6 (2006) 664-674
18. Stop TB Partnership and World Health Organization. Global Plan to Stop TB 2006-2015 (2006), World Health Organization, Geneva (WHO/HTM/STB/2006.35)
19. Tenover F.C., Crawford J.T., Huebner R.E., Geiter L.J., Horsburgh C.R., and Good R.C. The resurgence of tuberculosis: is your laboratory ready?. J. Clin. Microbiol. 31 (1993) 767-770
20. Tortoli E., Cichero P., Piersimoni C., Simonetti M.T., Gesu G., and Nista D. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J. Clin. Microbiol. 37 (1999) 3578-3582
21. Varma J.K., Wiriyakitjar D., Nateniyom S., Anuwatnonthakate A., Monkongdee P., Sumnapan S., Akksilp S., Sattayawuthipong W., Charunsuntonsri P., Rienthong S., Yamada N., Akarasewi P., Wells C.D., and Tappero J.W. Evaluating the potential impact of the new Global Plan to Stop TB: Thailand, 2004-2005. Bull. W.H.O. 85 (2007) 664-674
22. Williams-Bouyer N., Yorke R., Lee H.I., and Woods G.L. Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria. J. Clin. Microbiol. 38 (2000) 4167-4170
23. World Health Organization. In: W. H. Organization (Ed). Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2007 (2007), World Health Organization, Geneva (WHO/HTM/TB/2007.376)
24. World Health Organization. New WHO Policies: the use of liquid medium for culture and DST (2007), World Health Organization, Geneva. http://www.who.int/tb/dots/laboratory/policy/en/index.html (accessed 27 February 2008)
25. World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings (2007), World Health Organization, Geneva (WHO/HRM/TB/2007.379)